期刊文献+

胶束电动毛细管色谱法测定减肥保健品中的西布曲明、吲达帕胺、丁脲胺和氯噻嗪 被引量:20

Determination of Sibutramine,Indapamide,Bumetanide and Chlorothiazide in Mass-reducing Tonic by Micellar Electrokinetic Capillary Chromatography
下载PDF
导出
摘要 目的:建立了胶束电动毛细管色谱法同时测定减肥保健品中的西布曲明、吲达帕胺、丁脲胺和氯噻嗪的方法。方法:以10.0 mmol·L^(-1)磷酸盐缓冲溶液-15.0 mmol·L^(-1)SDS(含35%乙腈,V/V,pH 7.5)为电泳介质,未涂层弹性石英毛细管(50μm×48cm,有效长度为40 cm)为分离通道,检测波长为210 nm,压力进样(5kPa×10s)。结果:西布曲明、吲达帕胺、丁脲胺和氯噻嗪的线性范围分别为4.0~100.0 m·L^(-1),2.0~80.0 mg·L^(-1),2.0~80.0 mg·L^(-1),2.0~80.0 mg·L^(-1),检出限分别为1.0,0.5,0.5,0.5 mg·L^(-1),5次重复测定的相对偏差为2.8%~4.5%;样品加标回收率为89%~103%。结论:该法简便快捷,准确可靠,用于中药成分减肥保健品分析,结果令人满意。 Objective:To develop a method for determination of sibutramine,indapamide, bumetanide and chlorothiazide in weigh - reducing tonic by micellar electrokinetic capillary chromatography. Method: The running buffer was composed 10. 0 mmol · L^-1 phosphate and 15.0 mmol L^-1 SDS ( pH was adjusted to 7.5 with phosphoric acid). The separation was performed on a fused -silica capillary (50 m 48 cm,40 cm of effective length). The detection was set at 210 nm and 5 kPa 10 s pressure injection was used. Results:the linear ranges were 4. 0 - 1130. 0 mg · L^-1,2.0-80.0 mg · L^-1,2.0 -80.0 mg · L^-1,2.0 -80.0 mg · L^-1,with a detectim limits of 1.0,0.5, 0. 5,0. 5 mg · L^- 1 for sibutramine, indapamide, bumetanide and chlorothiazide, respectively. The relative standard devivatims were 2.8% -4.5% (n = 5 ),and the average recoveries ranged from 89% to 103%. Conclusion:The method is simple, rapid, accurate and suitable for simultaneous determination of sibutramine, indapamide, bumetanide and chlorothiazide in weigh -reducing tonic with satisfactory results.
出处 《药物分析杂志》 CAS CSCD 北大核心 2005年第12期1456-1459,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 胶束电动毛细管色谱 减肥保健品 西布曲明 吲达帕胺 丁脲胺 氯噻嗪 micellar electrokinetic capillary chromatography, weigh - reducing tonic, chlorothiazide, indapamide,sibutramine, bumetanide
  • 相关文献

参考文献12

二级参考文献28

  • 1王泽民.当代药物结构全集[M].北京:北京科学技术出版社,1993.2325.
  • 2章鸣.早期研究开发中的新减肥药[J].国外药讯,1998,10(9):41-41.
  • 3Expert panel on the identification, evaluation and treatment of overweight in adults. Clinical guideline on the identification, evaluation and treatment of overweight and obesity in adult: Executive Summary[J]. Am J Clin Nutr, 1998, 68: 899-917.
  • 4Stock MJ. Sibutramine: a review of the Pharmacology of novel anti-obesity agent [ J]. Int J Obes Relat Metab Disord, 1997, 21( suppl 1 ) : s25-s29.
  • 5Gokcel A, Gumurdulu Y, Karakose H, et al. Evaluation of the safety and efficacy of sibutramine, orlistat and metforming in the treatment of obesity [ J ]. Diabetes Obes Metab, 2002, 4 ( 1 ) :49-55.
  • 6Kutsuna H, Fujii S, Kitamura K, et al. Identification and determination of platelet aggregation inhibitor from safflower. Yakugaku Zasshi, 1988,108 (11) :1101.
  • 7Yang JW. ( Sepracor Inc. ) Methods and composition for treating depression and other disorders using optically pure ( + ) sibutramine.PCT Int. Appl. WO 9400047 ( Cl. A51K31/45) ,06 Jan 1994,US Appl. 903034,23 Jun 1992 ;40pp.
  • 8Yang JW. ( Sepracor Inc. ) Pharnlaceutical compositions for treating depression and other cerebral disorders containing optically pure( - )sibutramine. PCT Int. Appl. WO 9400114( Cl. A61 K31/135 ) ,06 Jan1994, US Appl. 903040,23 Jun 1992 ;40pp.
  • 9Radhakrishna T, Narayana CL, Rao DS,et al. LC method for the determination of assay and purity of sibutramine hydrochlorlde and its enantiomers by chiral chromatography. J Pharm Biomed Anal ,2000,22 :627.
  • 10Lelievnre F, Gareil P. Selectivity in capillary electrophoresis : application to chiral separations with cyclodextrins. Anal Chem, 1997,69:385.

共引文献73

同被引文献336

引证文献20

二级引证文献171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部